AKT1 and type 2 diabetes mellitus: The activation of the PI3K/AKT signaling pathway can significantly improve various abnormal indexes of T2DM in vivo and in vitro, regulate the metabolic levels of glucose and lipid protein in insulin target organs and cells, improve insulin resistance to some extent and play a hypoglycemic role.